Confined or spread disease-Spread with distant metastasis - Page 2 of 22 Posts on Medivizor
Navigation Menu

Confined or spread disease-Spread with distant metastasis Posts on Medivizor

Chemotherapy delivered directly in the liver in patients with colorectal cancer that has spread to the liver.

Chemotherapy delivered directly in the liver in patients with colorectal cancer that has spread to the liver.

Posted by on May 16, 2021 in Colorectal cancer | 0 comments

In a nutshell The aim of this study was to evaluate if hepatic arterial infusion chemotherapy (HAIC) could be beneficial for patients with colorectal cancer (CRC) that has spread to the liver (liver metastasis; LM). The study found that HAIC improved the outcome of these patients. Some background CRC is one of the most common types of cancer...

Read More

Searching for patients with solid tumors with abnormal genetic changes to trial an experimental medication

Searching for patients with solid tumors with abnormal genetic changes to trial an experimental medication

Posted by on Apr 30, 2021 in Breast cancer | 0 comments

In a nutshell This study is searching for participants with advanced solid tumors including breast cancer to examine the safety and effectiveness of experimental drug avapritinib (AYVAKIT). The main outcomes to be measured are the response to treatment and side effects. This trial is being conducted in Texas, US. The details Some cancers grow as a...

Read More

Does targeted therapy improve the outcome of patients treated with stereotactic radiosurgery for brain metastasis in melanoma?

Does targeted therapy improve the outcome of patients treated with stereotactic radiosurgery for brain metastasis in melanoma?

Posted by on Apr 30, 2021 in Melanoma | 0 comments

In a nutshell The aim of this study was to evaluate the outcomes of combining stereotactic radiosurgery (SRS) with BRAF inhibitors for brain metastasis in patients with melanoma. The study found that adding BRAF inhibitors to STS improved patient outcomes. Some background Melanoma is one of the most aggressive forms of skin cancer....

Read More

Comparing the safety and effectiveness of pyrotinib versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer

Comparing the safety and effectiveness of pyrotinib versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer

Posted by on Apr 18, 2021 in Breast cancer | 0 comments

In a nutshell This study compared the safety and effectiveness of pyrotinib (SHR-1258) plus capecitabine (Xeloda) versus lapatinib (Tyverb) plus capecitabine in patients with metastatic human epidermal growth factor (HER2)-positive breast cancer (BC) after previous treatment with trastuzumab (Herceptin) and chemotherapy. The data...

Read More

Real-world outcomes of fulvestrant as first-line treatment of postmenopausal women with advanced breast cancer.

Real-world outcomes of fulvestrant as first-line treatment of postmenopausal women with advanced breast cancer.

Posted by on Apr 10, 2021 in Breast cancer | 0 comments

In a nutshell This study investigated the effectiveness of fulvestrant (Faslodex) as a first-line treatment for postmenopausal women with estrogen receptor-positive (ER+) metastatic breast cancer (BC) in a real-world setting. The data showed that the outcomes of these patients in the real-world setting were similar to clinical trials...

Read More

Can abemaciclib plus hormonal therapy be considered a safe and effective treatment in older patients with advanced breast cancer?

Can abemaciclib plus hormonal therapy be considered a safe and effective treatment in older patients with advanced breast cancer?

Posted by on Apr 3, 2021 in Breast cancer | 0 comments

In a nutshell This article looked at the safety and effectiveness of abemaciclib (Verzenios) plus hormonal therapy (HT) in older patients with hormone receptor-positive (HR+)/HER-2 negative (HER2-) advanced breast cancer (BC). The authors concluded that abemaciclib + HT was effective across all age groups and while higher rates of side effects...

Read More

Immunotherapy and radiotherapy combinations to treat melanoma spread to the brain

Immunotherapy and radiotherapy combinations to treat melanoma spread to the brain

Posted by on Mar 6, 2021 in Melanoma | 0 comments

In a nutshell This study evaluated the use of immunotherapy (IT) and/or radiotherapy (RT) for the treatment of melanoma with brain metastasis (MBM). The study found that combining IT with RT improved survival outcomes for these patients. Some background The spread of cancer from the original tumor to other parts of the body is called metastasis....

Read More

Evaluating the effectiveness and safety of stereotactic ablative body radiotherapy in advanced cancer

Evaluating the effectiveness and safety of stereotactic ablative body radiotherapy in advanced cancer

Posted by on Feb 26, 2021 in Melanoma | 0 comments

In a nutshell This study investigated the effectiveness and safety of stereotactic ablative radiation therapy (SABR) in the treatment of patients with oligometastatic (few metastases) cancer. The data showed that the use of SABR in these patients was associated with high overall survival and low toxicity. Some background Oligometastatic cancer (OMC)...

Read More

Is radiosurgery in combination with other cancer therapies safe in patients with brain metastasis?

Is radiosurgery in combination with other cancer therapies safe in patients with brain metastasis?

Posted by on Jan 31, 2021 in Breast cancer | 0 comments

In a nutshell The aim of this study was to evaluate the safety of giving stereotactic radiosurgery (SRS) at the same time as other cancer treatments for patients who have brain metastasis. The study found that SRS given in combination with chemotherapy, immunotherapy, or targeted therapy was safe with low levels of side effects. Some background The...

Read More

Is radiosurgery in combination with other cancer therapies safe in patients with brain metastasis?

Is radiosurgery in combination with other cancer therapies safe in patients with brain metastasis?

Posted by on Jan 31, 2021 in Melanoma | 0 comments

In a nutshell The aim of this study was to evaluate the safety of giving stereotactic radiosurgery (SRS) at the same time as other cancer treatments for patients who have brain metastasis. The study found that SRS given in combination with chemotherapy, immunotherapy, or targeted therapy was safe with low levels of side effects. Some background...

Read More